Study of telitacicept injection in healthy volunteers
This trial tests a new way to give a drug called telitacicept, comparing a pre-filled injector to the standard powder version. It helps researchers understand how the drug works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 50 years old.
- Your weight should be 55-70 kg (for men) or 50-65 kg (for women), with a BMI between 18 and 28.
- You must be in good general health, with no major medical conditions.
- You cannot have a history of bleeding disorders, certain allergies, or recent participation in another drug trial.
- You must be willing to avoid alcohol, smoking, caffeine, and other medications during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called LX22001 in healthy volunteers to see how it is processed in the body and if it is safe. It is a first-in-human trial, so you must be in good health and meet specific age, weight, and lifestyle requirements.
This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This early-phase trial tests the safety of a new drug called NTB003 in healthy people. It looks at how the drug moves through the body and affects it, which is a first step toward possibly treating certain conditions.
This is an early Phase 1 trial testing a new investigational drug called CM326 given as an injection. The study measures how your body absorbs, distributes, and eliminates the drug. Researchers are enrolling only healthy volunteers to understand the drug's basic safety and how it moves through the body.
This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.